Endogenous circadian rhythm sleep disorders through the lens of nonparametric variables of actigraphy: an exploratory study in myotonic dystrophy type 1

📖 Top 20% JournalJan 17, 2026Sleep medicine

Sleep-wake cycle problems in myotonic dystrophy type 1 measured by activity tracking

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

9.1% of DM1 patients exhibited a delayed sleep phase disorder or irregular sleep-wake rhythm disorder.

DM1 patients showed poorer sleep quality and delayed sleep-wake episodes compared to healthy controls.
Reduced daylight exposure was observed in DM1 patients relative to healthy control subjects.
DM1 patients with irregular sleep-wake rhythm disorders had significantly lower inter-daily stability and relative amplitude.
Higher intra-daily variability was found in DM1 patients with irregular sleep-wake rhythm disorders compared to those with normal sleep patterns.
DM1 patients with circadian rhythm sleep-wake disorders were more likely to experience excessive daytime sleepiness.

AI simplified

BACKGROUND: A recent case study reported a non-24 h sleep-wake disorder in a patient with myotonic dystrophy type 1 (DM1). Research on intrinsic circadian rhythm sleep-wake disorders (CRSWDs) in DM1 patients is though lacking. This study utilized actigraphy to ascertain the presence of CRSWDs in DM1 patients and establish a comparison with healthy control subjects.

METHODS: Thirty-three patients with genetic diagnosis of DM1 and 33 age- and sex-matched healthy control subjects wore an actigraph and filled out a sleep diary for two consecutive weeks. Sleep, light exposure, and nonparametric measures were computed from actigraphic data.

RESULTS: DM1 patients exhibit poorer sleep quality and delayed sleep-wake episodes as well as reduced daylight exposure compared to healthy control subjects. Importantly, 3 DM1 patients (9.1 %) had a delayed sleep phase disorder and 3 DM1 patients had an irregular sleep-wake rhythm disorder (ISWRD) (9.1 %) whereas no control subject exhibited a CRSWD. DM1 patients with an ISWRD presented lower inter-daily stability (IS) (0.16 vs. 0.44, p < 0.05) and relative amplitude (RA) (0.36 vs. 0.79, p < 0.01) as well as higher intra-daily variability (IV) (1.22 vs. 0.79, p < 0.05) than DM1 patients with a normal sleep phenotype. DM1 patients with CRSWDs were more likely to exhibit excessive daytime sleepiness (EDS) than those with a normal sleep phenotype (83.3 % vs. 37.0 %, p < 0.05).

CONCLUSIONS: Core clinical implications are the need to systematically screen DM1 patients for CRSWDs and apply a multimodal chronotherapy (sleep hygiene, timed light, and melatonin). Recognizing and treating CRSWDs can help address significant sleep disturbances, like EDS.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗